ArticleNature communications2025

Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy.

Shunying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.